Cargando…
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial
BACKGROUND: Cerebral small vessel disease is a common cause of vascular cognitive impairment in older people, with no licensed treatment. Cerebral blood flow is reduced in small vessel disease. Tadalafil is a widely prescribed phosphodiesterase-5 inhibitor that increases blood flow in other vascular...
Autores principales: | Pauls, Mathilde M. H., Clarke, Natasha, Trippier, Sarah, Betteridge, Shai, Howe, Franklyn A., Khan, Usman, Kruuse, Christina, Madigan, Jeremy B., Moynihan, Barry, Pereira, Anthony C., Rolfe, Debbie, Rostrup, Egill, Haig, Caroline E., Barrick, Thomas R., Isaacs, Jeremy D., Hainsworth, Atticus H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440904/ https://www.ncbi.nlm.nih.gov/pubmed/28532471 http://dx.doi.org/10.1186/s13063-017-1973-9 |
Ejemplares similares
-
Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial
por: Pauls, Mathilde MH, et al.
Publicado: (2023) -
The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment
por: Pauls, Mathilde M.H., et al.
Publicado: (2022) -
The effect of phosphodiesterase-5 inhibitors on cerebral blood flow
in humans: A systematic review
por: Pauls, Mathilde MH, et al.
Publicado: (2017) -
Test–retest reliability of arterial spin labelling for cerebral blood flow in older adults with small vessel disease
por: Binnie, Lauren R., et al.
Publicado: (2022) -
Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke—a pilot study
por: Ölmestig, Joakim, et al.
Publicado: (2020)